Report Detail

Other Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2019-2025

  • RnM3813069
  • |
  • 14 October, 2019
  • |
  • Global
  • |
  • 129 Pages
  • |
  • QYResearch
  • |
  • Other

This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott
Siemens
GE Healthcare
Accriva
Terumo
BioMerieux
Diasorin
Roche
Danaher Corporation
BD
Bio-Rad Laboratories
Cavidi
Cepheid
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
Euroimmun
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Market segment by Type, the product can be split into
Over-the-counter (OTC) Testing Kits
Prescription-based Testing Kits

Market segment by Application, split into
Bacterial Infections
Fungal Infection
Virus Infection
Cardiovascular Infection
Gastrointestinal Infection
Sexually Transmitted Disease (STD) Infection
Central Nervous System Infection
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Infectious Disease Point of Care Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Infectious Disease Point of Care Diagnostics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Over-the-counter (OTC) Testing Kits
      • 1.4.3 Prescription-based Testing Kits
    • 1.5 Market by Application
      • 1.5.1 Global Infectious Disease Point of Care Diagnostics Market Share by Application (2019-2025)
      • 1.5.2 Bacterial Infections
      • 1.5.3 Fungal Infection
      • 1.5.4 Virus Infection
      • 1.5.5 Cardiovascular Infection
      • 1.5.6 Gastrointestinal Infection
      • 1.5.7 Sexually Transmitted Disease (STD) Infection
      • 1.5.8 Central Nervous System Infection
      • 1.5.9 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Infectious Disease Point of Care Diagnostics Market Size
    • 2.2 Infectious Disease Point of Care Diagnostics Growth Trends by Regions
      • 2.2.1 Infectious Disease Point of Care Diagnostics Market Size by Regions (2019-2025)
      • 2.2.2 Infectious Disease Point of Care Diagnostics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Infectious Disease Point of Care Diagnostics Market Size by by Players
      • 3.1.1 Global Infectious Disease Point of Care Diagnostics Revenue by by Players (2014-2019)
      • 3.1.2 Global Infectious Disease Point of Care Diagnostics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Infectious Disease Point of Care Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Infectious Disease Point of Care Diagnostics Key Players Head office and Area Served
    • 3.3 Key Players Infectious Disease Point of Care Diagnostics Product/Solution/Service
    • 3.4 Date of Enter into Infectious Disease Point of Care Diagnostics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Infectious Disease Point of Care Diagnostics Market Size by Type (2014-2019)
    • 4.2 Global Infectious Disease Point of Care Diagnostics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 5.2 Infectious Disease Point of Care Diagnostics Key Players in North America
    • 5.3 North America Infectious Disease Point of Care Diagnostics Market Size by Type
    • 5.4 North America Infectious Disease Point of Care Diagnostics Market Size by Application

    6 Europe

    • 6.1 Europe Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 6.2 Infectious Disease Point of Care Diagnostics Key Players in Europe
    • 6.3 Europe Infectious Disease Point of Care Diagnostics Market Size by Type
    • 6.4 Europe Infectious Disease Point of Care Diagnostics Market Size by Application

    7 China

    • 7.1 China Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 7.2 Infectious Disease Point of Care Diagnostics Key Players in China
    • 7.3 China Infectious Disease Point of Care Diagnostics Market Size by Type
    • 7.4 China Infectious Disease Point of Care Diagnostics Market Size by Application

    8 Japan

    • 8.1 Japan Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 8.2 Infectious Disease Point of Care Diagnostics Key Players in Japan
    • 8.3 Japan Infectious Disease Point of Care Diagnostics Market Size by Type
    • 8.4 Japan Infectious Disease Point of Care Diagnostics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 9.2 Infectious Disease Point of Care Diagnostics Key Players in Southeast Asia
    • 9.3 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Type
    • 9.4 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size by Application

    10 India

    • 10.1 India Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 10.2 Infectious Disease Point of Care Diagnostics Key Players in India
    • 10.3 India Infectious Disease Point of Care Diagnostics Market Size by Type
    • 10.4 India Infectious Disease Point of Care Diagnostics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Infectious Disease Point of Care Diagnostics Market Size (2014-2019)
    • 11.2 Infectious Disease Point of Care Diagnostics Key Players in Central & South America
    • 11.3 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Type
    • 11.4 Central & South America Infectious Disease Point of Care Diagnostics Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.1.4 Abbott Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019))
      • 12.1.5 Abbott Recent Development
    • 12.2 Siemens
      • 12.2.1 Siemens Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.2.4 Siemens Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.2.5 Siemens Recent Development
    • 12.3 GE Healthcare
      • 12.3.1 GE Healthcare Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.3.4 GE Healthcare Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.3.5 GE Healthcare Recent Development
    • 12.4 Accriva
      • 12.4.1 Accriva Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.4.4 Accriva Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.4.5 Accriva Recent Development
    • 12.5 Terumo
      • 12.5.1 Terumo Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.5.4 Terumo Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.5.5 Terumo Recent Development
    • 12.6 BioMerieux
      • 12.6.1 BioMerieux Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.6.4 BioMerieux Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.6.5 BioMerieux Recent Development
    • 12.7 Diasorin
      • 12.7.1 Diasorin Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.7.4 Diasorin Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.7.5 Diasorin Recent Development
    • 12.8 Roche
      • 12.8.1 Roche Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.8.4 Roche Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.8.5 Roche Recent Development
    • 12.9 Danaher Corporation
      • 12.9.1 Danaher Corporation Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.9.4 Danaher Corporation Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.9.5 Danaher Corporation Recent Development
    • 12.10 BD
      • 12.10.1 BD Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Infectious Disease Point of Care Diagnostics Introduction
      • 12.10.4 BD Revenue in Infectious Disease Point of Care Diagnostics Business (2014-2019)
      • 12.10.5 BD Recent Development
    • 12.11 Bio-Rad Laboratories
    • 12.12 Cavidi
    • 12.13 Cepheid
    • 12.14 Diaxonhit
    • 12.15 Eiken Chemical
    • 12.16 EMD Millipore
    • 12.17 Epitope Diagnostic
    • 12.18 Euroimmun
    • 12.19 Gold Standard Diagnostics
    • 12.20 Hologic
    • 12.21 Immunetics
    • 12.22 InBios International

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Infectious Disease Point of Care Diagnostics. Industry analysis & Market Report on Infectious Disease Point of Care Diagnostics is a syndicated market report, published as Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Infectious Disease Point of Care Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.70
      4,522.05
      6,029.40
      3,595.80
      5,393.70
      7,191.60
      595,764.00
      893,646.00
      1,191,528.00
      328,029.00
      492,043.50
      656,058.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report